rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-12-6
|
pubmed:abstractText |
Aspirin is a common preventative therapy in patients at risk for cardiovascular diseases, yet little is known about how aspirin protects the vasculature in hypercholesterolemia. The present study determines whether aspirin, nitric oxide-releasing aspirin (NCX-4016), a selective cyclooxygenase (COX)-1 inhibitor (SC560), or genetic deficiency of COX-1 prevents the inflammatory and prothrombogenic phenotype assumed by hypercholesterolemic (HC) venules. Aspirin or NCX-4016 (60 mg/kg) was administered orally for the last week of a 2-wk HC diet. COX-1-deficient (COX-1(-/-)) and wild-type (WT) mice were transplanted with WT (WT/COX-1(-/-)) or COX-1(-/-) (COX-1(-/-)/WT) bone marrow, respectively. HC-induced adhesion of platelets and leukocytes in murine intestinal venules, observed with intravital fluorescence microscopy, was greatly attenuated in aspirin-treated mice. Adhesion of aspirin-treated platelets in HC venules was comparable to untreated platelets, whereas adhesion of SC560-treated platelets was significantly attenuated. HC-induced leukocyte and platelet adhesion in COX-1(-/-)/WT chimeras was comparable to that in SC560-treated mice, whereas the largest reductions in blood cell adhesion were in WT/COX-1(-/-) chimeras. NCX-4016 treatment of platelet recipients or donors attenuated leukocyte and platelet adhesion independent of platelet COX-1 inhibition. Platelet- and endothelial cell-associated COX-1 promote microvascular inflammation and thrombogenesis during hypercholesterolemia, yet nitric oxide-releasing aspirin directly inhibits platelets independent of COX-1.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, Dietary,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Donors,
http://linkedlifedata.com/resource/pubmed/chemical/Ptgs1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/SC 560,
http://linkedlifedata.com/resource/pubmed/chemical/nitroaspirin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0363-6135
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
293
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H3636-42
|
pubmed:meshHeading |
pubmed-meshheading:17933963-Animals,
pubmed-meshheading:17933963-Aspirin,
pubmed-meshheading:17933963-Blood Platelets,
pubmed-meshheading:17933963-Bone Marrow Transplantation,
pubmed-meshheading:17933963-Cardiovascular Diseases,
pubmed-meshheading:17933963-Cell Adhesion,
pubmed-meshheading:17933963-Chimera,
pubmed-meshheading:17933963-Cholesterol, Dietary,
pubmed-meshheading:17933963-Cyclooxygenase 1,
pubmed-meshheading:17933963-Cyclooxygenase Inhibitors,
pubmed-meshheading:17933963-Disease Models, Animal,
pubmed-meshheading:17933963-Endothelial Cells,
pubmed-meshheading:17933963-Endothelium, Vascular,
pubmed-meshheading:17933963-Hypercholesterolemia,
pubmed-meshheading:17933963-Leukocytes,
pubmed-meshheading:17933963-Male,
pubmed-meshheading:17933963-Membrane Proteins,
pubmed-meshheading:17933963-Mice,
pubmed-meshheading:17933963-Mice, Inbred C57BL,
pubmed-meshheading:17933963-Mice, Knockout,
pubmed-meshheading:17933963-Microscopy, Fluorescence,
pubmed-meshheading:17933963-Microscopy, Video,
pubmed-meshheading:17933963-Nitric Oxide Donors,
pubmed-meshheading:17933963-Platelet Adhesiveness,
pubmed-meshheading:17933963-Pyrazoles,
pubmed-meshheading:17933963-Venules
|
pubmed:year |
2007
|
pubmed:articleTitle |
Roles of platelet and endothelial cell COX-1 in hypercholesterolemia-induced microvascular dysfunction.
|
pubmed:affiliation |
Department of Molecular and Cellular Physiology, Health Sciences Center, Louisiana State University, 1501 Kings Highway, Shreveport, LA 71130-3932, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|